Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019
Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019
Pattern of risk of myocardial infarction (MI) in patients taking asthma medication: a study with the UK general practice research database (GPRD) Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021 Year: 2021
The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction Source: Annual Congress 2013 –COPD mechanisms Year: 2013
High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005
Coronary artery disease risk score calculation and evaluation of statin and antithrombotic drug use among patients admitted with an acute exacarbation of COPD Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
Myocardial infarction, heart failure and mortality in patients with COPD in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD Source: Eur Respir J 2005; 25: 634-639 Year: 2005
Impact of prior statin use on cardiac arrhythmias for patients hospitalized with pneumonia Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010
National trends in utilization and outcomes of percutaneous coronary intervention (PCI) among patients with and without COPD in Spain (2001-2011) Source: International Congress 2014 – COPD: points to ponder Year: 2014
Use of heart failure medications in outpatients with COPD and congestive heart failure: a Danish nationwide cohort study Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Statin use is associated with reduced mortality in COPD Source: Eur Respir J 2007; 29: 279-283 Year: 2007
Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
Use of beta-blockers in COPD patients with heart-disease. BBEPOC study Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010
Smoking status and in-hospital outcomes of ST elevation myocardial infarction patients in a Brazilian public university hospital Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Association of outpatient statin, ARB, and ACE inhibitor use on clinical outcomes for elderly subjects hospitalized with severe sepsis Source: Annual Congress 2013 –Interesting research questions Year: 2013